A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

"By blocking NPY's function in mouse models, we found we could substantially reduce the spread of pancreatic cancer to the ...

Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially ...

Leiting et al, Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study, Annals of Surgical Oncology (2025). DOI: 10.1245/s10434-025-17036-y ...

Because pancreatic cancer has few detectable symptoms in earlier stages, it is often not diagnosed until it has spread (metastasized) beyond the pancreas to the lymph nodes or other organs ...

About half of pancreatic cancer patients experience metastasis to the liver ... immune defense at the original pancreatic ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and genome duplication collide.

Activated fibroblasts promote tumor growth and spread, while also conferring resistance to treatments. This may be one of the reasons behind the high aggressiveness of pancreatic cancer ...

Pancreatic cancer is still among the most lethal cancers, with >45% of patients presenting distant metastasis at diagnosis, and with a 5-year survival rate of 13%. Known for its role in appetite and ...

As pancreatic cancer is very likely to spread, usually more than 30% of patients have metastasis when diagnosed, ruling out surgery. Moreover, given the anatomically complex positioning of the ...

Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Enzyme Promoting Tumor Growth and Spread in ...